1. Home
  2. BAFN vs ANIK Comparison

BAFN vs ANIK Comparison

Compare BAFN & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

N/A

Current Price

$6.16

Market Cap

175.3M

Sector

Finance

ML Signal

N/A

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

N/A

Current Price

$21.72

Market Cap

200.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BAFN
ANIK
Founded
1999
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
175.3M
200.9M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
BAFN
ANIK
Price
$6.16
$21.72
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $23.00
AVG Volume (30 Days)
85.7K
★ 95.2K
Earning Date
10-29-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 80.16
EPS
N/A
★ N/A
Revenue
N/A
★ $112,819,000.00
Revenue This Year
N/A
$7.82
Revenue Next Year
N/A
$5.44
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$4.26
$9.01
52 Week High
$9.56
$22.88

Technical Indicators

Market Signals
Indicator
BAFN
ANIK
Relative Strength Index (RSI) 42.37 56.57
Support Level $4.65 $20.13
Resistance Level $7.02 $22.70
Average True Range (ATR) 0.56 0.65
MACD 0.01 0.14
Stochastic Oscillator 45.13 70.15

Price Performance

Historical Comparison
BAFN
ANIK

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company that operates through its wholly owned subsidiary. The Company generates the majority of its revenue from interest on loans and noninterest income. The primary sources of funding for its loans are loan payments, deposits, and borrowings. It is dependent on noninterest income, which is derived from net gain on the sales of the guaranteed portion of government-guaranteed loans and service fee income. The company provides personal banking and business banking services.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: